Skip to content

Research on the Application of Digital Mindfulness Therapy in Patients with Diabetic Peripheral Neuropathy

Research on the Application of Digital Mindfulness Therapy in Patients with Diabetic Peripheral Neuropathy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113265
Enrollment
Unknown
Registered
2025-11-26
Start date
2025-12-16
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic peripheral neuropathy

Interventions

Control group:Receive routine care such as standardized out-of-hospital care and follow-up, mainly including lifestyle management, comprehensive management of blood sugar, blood lipids, blood pressure
Trial group:The experimental group received conventional treatment and d-MBIs. This intervention plan is based on the core framework of Mindfulness-Based Stress Reduction (MBSR) and the mindfulness co

Sponsors

The First Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria for DPN as stipulated in the "Diabetes Prevention and Treatment Guidelines of China (2024 Edition)"; 2. Age 18<=age<=80 years; 3. Capable of operating a smartphone; 4. Clear consciousness and no communication disorders; 5. Voluntarily participates in this study and signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with acute complications of diabetes and severe infections; 2. Those with other severe organic disorders such as arrhythmia, cerebral infarction, severe bleeding and abnormal coagulation function, etc; 3. Those who received other psychological treatment or intervention during the study, or those taking psychotropic drugs; 4. Those with asymmetrical lesions and significant motor dysfunction more than sensory dysfunction; 5. Patients with implanted cardiac pacemakers or metallic implants in their bodies; 6. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Psychological distress;Nerve conduction velocity;

Secondary

MeasureTime frame
Capillary blood glucose;Glycosylated hemoglobin;Blood pressure;Blood fat;Living quality;Anxiety;Mindfulness;

Countries

China

Contacts

Public ContactJia Lihong

The First Affiliated Hospital of Dalian Medical University

jialihong2199@163.com+86 180 9887 2199

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026